Alcohol-related hepatocellular carcinoma is a heterogenous condition: Lessons from a latent class analysis

被引:2
|
作者
Costentin, Charlotte E. [1 ,2 ]
Minoves, Melanie [3 ,4 ,5 ]
Kotzki, Sylvain [3 ,4 ]
Farges, Olivier [6 ]
Goutte, Nathalie [7 ,8 ,9 ]
Decaens, Thomas [1 ,2 ]
Bailly, Sebastien [3 ,4 ]
机构
[1] Grenoble Alpes Univ, Inst Adv Biosci, INSERM U1209, CNRS UMR, Grenoble, France
[2] Grenoble Alpes Univ Hosp, Hepatol Gastroenterol & Digest Oncol, La Tronche, France
[3] Grenoble Alpes Univ, INSERM U1300, Lab HP2, Grenoble, France
[4] Grenoble Alpes Univ, Grenoble Alpes Univ Hosp, Grenoble, France
[5] Grenoble Alpes Univ Hosp, Dept Pharm, La Tronche, France
[6] Beaujon Hosp, Hepatobiliary Surg Dept, Clichy, France
[7] DHU Hepatinov, INSERM UMRS 1193, Villejuif, France
[8] Paris Saclay Univ, Paul Brousse Hosp, AP HP, Ctr Hepatobiliaire, Villejuif, France
[9] DHU Hepatinov FHU Hepatinov, Villejuif, France
关键词
alcohol; cluster; liver cancer; survival; ADMINISTRATIVE DATA; LIVER; CIRRHOSIS; SURVIVAL;
D O I
10.1111/liv.15256
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Alcohol-associated hepatocellular carcinoma (AL-HCC) poor prognosis has been attributed to diagnosis at a later stage. However, host factors and specific health trajectories have been associated with severe outcomes in alcohol-related liver disease. We hypothesize AL-HCC is not a homogeneous condition but encompasses subgroups yielding different outcomes. Aims Our aim was to provide a first attempt at a clinical phenotyping of AL-HCC. Methods We analysed data for the calendar years 2007-2013 from the French nationwide administrative hospital database. We selected patients with AL-HCC only. Clustering of AL-HCC phenotypes was performed by latent class analysis (LCA). Results The study included 11 363 patients with AL-HCC, mainly male (89.6%), median age 67 years [IQR: 61; 74] of which 71.2% had at least one metabolic comorbidity. Five phenotypes were identified. Phenotype 1 (41.4%) displayed high rates of unrecognized cirrhosis prior to HCC diagnosis (81%), low rates of metabolic comorbidities (diabetes 13%), and mostly compensated liver disease at HCC diagnosis while the four other phenotypes displayed high rates of metabolic comorbidities (diabetes up to 100%), various patterns of liver disease trajectories and overall 42% unrecognized cirrhosis. In adjusted survival analysis, compared to phenotype 1, risk of death after HCC diagnosis was significantly different for all phenotypes. Conclusion LCA uncovers AL-HCC is a heterogeneous condition with distinct phenotypes yielding specific survival outcomes. Frequent unrecognized cirrhosis prior to HCC underlines the urgent need for implementing strategies to identify the underlying liver disease prior to HCC onset in patients with documented alcohol use disorders and metabolic comorbidities.
引用
收藏
页码:1638 / 1647
页数:10
相关论文
共 50 条
  • [1] Alcohol-related hepatocellular carcinoma in France: analysis from the CHANGH study
    Costentin, Charlotte E.
    Decaens, Thomas
    Lahmek, Pierre
    Becker, Claire
    Bader, Robert
    Marks, Anne-Berangere
    Condat, Bertrand
    Gelu-Simeon, Moana
    Labadie, Helene
    Pauwels, Arnaud
    Pofelski, Joanna
    Seyrig, Jacques Arnaud
    Cocquart, Jean Louis
    Denis, Jacques
    Rosa, Isabelle
    [J]. HEPATOLOGY, 2013, 58 : 1244A - 1245A
  • [2] Hepatocellular carcinoma in the setting of alcohol-related liver disease
    Ganne-Carrie, Nathalie
    Nahon, Pierre
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (02) : 284 - 293
  • [3] GWAS reveals variants for alcohol-related hepatocellular carcinoma
    Hindson J.
    [J]. Nature Reviews Gastroenterology & Hepatology, 2022, 19 (2) : 79 - 79
  • [4] Alcohol use and hepatocellular carcinoma risk in patients with alcohol-related cirrhosis
    Kraglund, Frederik
    Birn-Rydder, Rasmine
    Sorensen, Mia Dahl
    Abazi, Rozeta
    Villadsen, Gerda Elisabeth
    Jepsen, Peter
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, 58 (11) : 1321 - 1327
  • [5] Constitutional and functional genetics of human alcohol-related hepatocellular carcinoma
    Nahon, Pierre
    Nault, Jean-Charles
    [J]. LIVER INTERNATIONAL, 2017, 37 (11) : 1591 - 1601
  • [6] Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis
    Jepsen, Peter
    Kraglund, Frederik
    West, Joe
    Villadsen, Gerda E.
    Sorensen, Henrik Toft
    Vilstrup, Hendrik
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (05) : 1030 - 1036
  • [7] Alcohol dehydrogenase 3*1 genotype is associated with alcohol-related hepatocellular carcinoma
    Stickel, F
    Benesova, M
    Schuppan, D
    Homann, N
    Hahn, EG
    Seitz, HK
    [J]. JOURNAL OF HEPATOLOGY, 2002, 36 : 84 - 84
  • [8] A latent class analysis of alcohol-related problems among adults who drank in the past year
    Frankeberger, Jessica
    Coulter, Robert W. S.
    Mair, Christina
    [J]. JOURNAL OF SUBSTANCE USE, 2024, 29 (05) : 753 - 758
  • [9] Identification of special key genes for alcohol-related hepatocellular carcinoma through bioinformatic analysis
    Zhang, Xiuzhi
    Kang, Chunyan
    Li, Ningning
    Liu, Xiaoli
    Zhang, Jinzhong
    Gao, Fenglan
    Dai, Liping
    [J]. PEERJ, 2019, 7
  • [10] Efficacy and safety of sorafenib in patients with alcohol-related hepatocellular carcinoma: A sub-analysis from the SHARP trial
    Craxi, A.
    Porta, C.
    Sangiovanni, A.
    Seitz, J.
    Moscovici, M.
    Shan, M.
    Nadel, A.
    Voliotis, D.
    Bruix, J.
    Llovet, J. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)